Capillary Technologies India Ltd
Press release on Q1 Financial results
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 04 Aug 2026, 01:57 PM IST · BSE ID: 9cd32d9d-433d-4e2d-8789-6b1665bacf0c
View Original BSE Filing (PDF)
💡
In Simple Terms
Capillary Technologies reported increased sales and profits in the first quarter, boosted by existing clients, new contracts, and a recent acquisition.
🤖 AI Summary
- Capillary Technologies reported Q1 FY27 operating revenue of ₹ 2,566.4 Mn, a 43% year-on-year growth.
- Adjusted EBITDA for Q1 FY27 increased 132% year-on-year to ₹ 440.2 Mn.
- Normalized Profit After Tax for Q1 FY27 grew 3,320% year-on-year to ₹ 254.4 Mn.
- Growth was attributed to existing customer expansion, new contracts, and the SessionM acquisition in May 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Operating Revenue
₹ 2,566.4 Mn
+43%
Adjusted EBITDA
₹ 440.2 Mn
+132%
PAT
₹ (-) 95.5 Mn
-1,383%
Normalized PAT
₹ 254.4 Mn
+3,320%
🏢 How This Affects the Company
The company's operating revenue growth of 43% reflects expansion within its existing customer base and contributions from new annual contract values. The recent SessionM acquisition in May 2026 also contributed to this revenue increase.
Profitability improved significantly with Adjusted EBITDA growing by 132% to ₹ 440.2 Mn and Normalized PAT increasing by 3,320% to ₹ 254.4 Mn, driven by operational efficiencies.
The integration of SessionM's team and clientele is a management priority, indicating ongoing operational adjustments to assimilate the acquired business.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results announcement.
👤
Who Is Affected
All shareholders are indirectly affected as the financial performance impacts the company's valuation and future prospects.
🔍
Management Signal
Management is prioritizing sustainable organic growth, profitability, and the seamless integration of the SessionM acquisition.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — check for sustained revenue and profit growth.
Updates on SessionM integration progress and its contribution to future quarters.
Details on the nature and impact of 'exceptional/one-off items' affecting PAT.
MEDIUM RISK
Significant negative reported PAT despite strong normalized profitability indicates underlying adjustments requiring further scrutiny.
💡 Investor Takeaway
Capillary Technologies reported Q1 FY27 operating revenue of ₹ 2,566.4 Mn, up 43% year-on-year. Adjusted EBITDA increased 132% to ₹ 440.2 Mn, and Normalized PAT rose 3,320% to ₹ 254.4 Mn. Reported PAT was ₹ (-) 95.5 Mn.
⚖️ Strengths & Concerns
✅ Positives
- Operating Revenue for Q1 FY27 grew 43% year-on-year to ₹ 2,566.4 Mn, indicating strong top-line expansion.
- Normalized PAT increased by 3,320% year-on-year to ₹ 254.4 Mn, reflecting improved operational efficiencies and integration synergies.
⚠️ Concerns
- Reported PAT for Q1 FY27 was ₹ (-) 95.5 Mn, a significant decline of 1,383% year-on-year from ₹ 7.4 Mn.
- The substantial difference between reported PAT and Normalized PAT suggests significant exceptional/one-off items affected statutory profit.
📅 Company Track Record
Capillary Technologies previously reported a standalone profit after tax of ₹ 77.65 million for Q1 FY27, up from a ₹ (51.21) million loss year-on-year, as per a filing on August 4, 2026.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Capillary Technologies' Operating Revenue for Q1 FY27?
Capillary Technologies reported an Operating Revenue of ₹ 2,566.4 Mn for the quarter ended June 30, 2026, which is a 43% year-on-year growth.
How much was Capillary Technologies' Adjusted EBITDA in Q1 FY27?
The Adjusted EBITDA for Capillary Technologies in Q1 FY27 was ₹ 440.2 Mn, registering a year-on-year growth of 132%.
What was Capillary Technologies' Reported Profit After Tax (PAT) for Q1 FY27?
Capillary Technologies reported a PAT of ₹ (-) 95.5 Mn for Q1 FY27, compared to ₹ 7.4 Mn in the same quarter last year, representing a decline of 1,383%.
What was Capillary Technologies' Normalized Profit After Tax (PAT) for Q1 FY27?
Capillary Technologies' Normalized PAT for Q1 FY27 was ₹ 254.4 Mn, which is an exponential growth of 3,320% year-on-year compared to ₹ 7.4 Mn.
What contributed to Capillary Technologies' revenue growth in Q1 FY27?
Revenue growth in Q1 FY27 was driven by healthy expansion within the existing customer base, growth in new annual contract value contributions, and the addition of SessionM, acquired in May 2026.
Questions based on this BSE filing only. For information purposes.